GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Sinew Pharma Inc (ROCO:6634) » Definitions » Total Equity

Sinew Pharma (ROCO:6634) Total Equity : NT$1,263.76 Mil (As of Jun. 2024)


View and export this data going back to 2017. Start your Free Trial

What is Sinew Pharma Total Equity?

Sinew Pharma's total equity for the quarter that ended in Jun. 2024 was NT$1,263.76 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

Sinew Pharma Total Equity Historical Data

The historical data trend for Sinew Pharma's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sinew Pharma Total Equity Chart

Sinew Pharma Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Total Equity
Get a 7-Day Free Trial Premium Member Only 240.17 168.77 435.76 1,568.80 1,458.50

Sinew Pharma Semi-Annual Data
Dec14 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Jun24
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,568.80 1,518.01 1,458.50 1,409.94 1,263.76

Sinew Pharma Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Sinew Pharma's Total Equity for the fiscal year that ended in Dec. 2022 is calculated as

Total Equity=Total Assets(Q: Dec. 2022 )-Total Liabilities(Q: Dec. 2022 )
=1487.161-28.658
=1,458.50

Sinew Pharma's Total Equity for the quarter that ended in Jun. 2024 is calculated as

Total Equity=Total Assets(Q: Jun. 2024 )-Total Liabilities(Q: Jun. 2024 )
=1293.287-29.525
=1,263.76

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sinew Pharma Total Equity Related Terms

Thank you for viewing the detailed overview of Sinew Pharma's Total Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Sinew Pharma Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Sinew Pharma Inc (ROCO:6634) » Definitions » Total Equity
Comparable Companies
ROCO:8279 TPE:1762 ROCO:6794 ROCO:6733 ROCO:6492 ROCO:1777 ROCO:4169 ROCO:6461 TPE:6657 TPE:1734 OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX
Traded in Other Exchanges
N/A
Address
C516, Building C, Number 99, Lane 130, Section 1, Xueyin Road, Nangang District, Taipei, TWN, 11571
Website
https://www.sinewpharma.com
Sinew Pharma Inc is a Taiwan-based biopharmaceutical company. The company is mainly engaged in the research and development of new drugs for the treatment of liver diseases and pain relief. Its drug candidates includes SNP-610, SNP-630, SNP-810, SNP-820, SNP-830 and SNP-840.

Sinew Pharma Headlines

No Headlines